Cargando…
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
The recent developments in immuno-oncology have opened an unprecedented avenue for the emergence of vaccine strategies. Therapeutic DNA cancer vaccines are now considered a very promising strategy to activate the immune system against cancer. In the past, several clinical trials using plasmid DNA va...
Autores principales: | Lopes, Alessandra, Vandermeulen, Gaëlle, Préat, Véronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449928/ https://www.ncbi.nlm.nih.gov/pubmed/30953535 http://dx.doi.org/10.1186/s13046-019-1154-7 |
Ejemplares similares
-
Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma
por: Lopes, Alessandra, et al.
Publicado: (2017) -
Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model
por: Bausart, Mathilde, et al.
Publicado: (2022) -
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site
por: Lopes, Alessandra, et al.
Publicado: (2019) -
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
por: Lopes, Alessandra, et al.
Publicado: (2018) -
Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma
por: Kos, Spela, et al.
Publicado: (2019)